FHCIX
Fidelity Advisor Health Care Fund
1W: -2.4%
1M: -2.0%
3M: +4.3%
YTD: +16.4%
1Y: +14.1%
3Y: +34.6%
5Y: +13.4%
$75.16
+0.32 (+0.43%)
Weekly Expected Move ±2.4%
$71
$73
$75
$77
$78
ETF-Level Metrics
AUM$3.4B
Holdings99
Top 10 Wt40.5%
Beta0.70
% Profitable22%
Coverage95%
Portfolio Valuation
P/E38.8
P/B7.0
P/S4.0
EV/EBITDA24.4
P/FCF32.2
PEG3.88
Profitability & Returns
Gross Margin45.5%
Net Margin9.9%
ROE20.3%
ROA7.3%
ROIC14.7%
Div Yield0.63%
Leverage & Liquidity
Debt/Equity0.75
Debt/Assets0.28
Net Debt/EBITDA1.5x
Interest Cov11.0x
Current Ratio1.22
Quick Ratio1.06
Growth (YoY)
Revenue+27.4%
Net Income+30.1%
EPS+35.7%
FCF+40.7%
EBITDA+31.5%
Rev CAGR 3Y+30.1%
Quality Scores
Piotroski F5.8
Altman Z16.03
IS Quality67.0
IS Overall58.6
IS Value39.1
Median P/E-5.7
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 99 | 96.5% | -12.1 |
| Other | 43 | 3.6% | — |
Smart Money Overlap
2 holdings with signals
Showing 50 of 142 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 7.66% | $239.0M | 201,466 | 38.2 | $1.1T | Healthcare |
| 2 | Danaher Corp | DHR | 6.75% | $210.6M | 930,816 | 37.9 | $150.5B | Healthcare |
| 3 | Thermo Fisher Scientific Inc | TMO | 6.31% | $196.7M | 289,427 | 35.2 | $242.1B | Healthcare |
| 4 | UnitedHealth Group Inc | UNH | 4.17% | $130.1M | 347,046 | 23.9 | $337.7B | Healthcare |
| 5 | Johnson & Johnson | JNJ | 3.78% | $117.9M | 440,711 | 29.6 | $617.0B | Healthcare |
| 6 | AbbVie Inc | ABBV | 3.62% | $112.9M | 428,957 | 74.0 | $464.3B | Healthcare |
| 7 | Argenx SE ADR | ARGX | 2.09% | $65.3M | 67,292 | 33.3 | $57.2B | Healthcare |
| 8 | Merck & Co Inc | MRK | 2.09% | $65.1M | 435,976 | 114.5 | $356.4B | Healthcare |
| 9 | West Pharmaceutical Services Inc | WST | 2.06% | $64.2M | 170,557 | 46.4 | $25.7B | Healthcare |
| 10 | Ascendis Pharma A/S | ASND | 1.96% | $61.0M | 267,363 | 16.7 | $14.2B | Healthcare |
| 11 | Alnylam Pharmaceuticals Inc | ALNY | 1.78% | $55.5M | 218,406 | 36.0 | $29.4B | Healthcare |
| 12 | Agilent Technologies Inc | A | 1.75% | $54.7M | 312,267 | 33.0 | $47.4B | Healthcare |
| 13 | Viatris Inc | VTRS | 1.67% | $52.0M | 2,868,521 | -48.9 | $20.5B | Healthcare |
| 14 | Natera Inc | NTRA | 1.65% | $51.5M | 124,210 | -301.7 | $58.8B | Healthcare |
| 15 | Guardant Health Inc | GH | 1.48% | $46.2M | 259,760 | -50.9 | $23.9B | Healthcare |
| 16 | 10X Genomics Inc Class A | TXG | 1.45% | $45.1M | 501,319 | -158.5 | $11.9B | Healthcare |
| 17 | Revolution Medicines Inc | RVMD | 1.45% | $45.1M | 220,381 | -23.3 | $43.9B | Healthcare |
| 18 | Waters Corp | WAT | 1.43% | $44.5M | 100,443 | 105.8 | $41.7B | Healthcare |
| 19 | Oruka Therapeutics Inc | ORKA | 1.32% | $41.3M | 502,815 | -34.2 | $5.1B | Healthcare |
| 20 | UCB SA | UCB.BR | 1.32% | $41.1M | 175,342 | 17.7 | $38.9B | Healthcare |
| 21 | CVS Health Corp | CVS | 1.29% | $40.2M | 461,602 | 22.6 | $110.3B | Healthcare |
| 22 | Gilead Sciences Inc | GILD | 1.25% | $39.1M | 258,217 | -55.7 | $179.5B | Healthcare |
| 23 | Boston Scientific Corp | BSX | 1.23% | $38.3M | 873,259 | 17.2 | $63.3B | Healthcare |
| 24 | Repligen Corp | RGEN | 1.22% | $38.1M | 195,676 | 245.5 | $10.3B | Healthcare |
| 25 | Enliven Therapeutics Inc | ELVN | 1.18% | $36.7M | 789,566 | -28.6 | $3.4B | Healthcare |
| 26 | Cogent Biosciences Inc | COGT | 1.15% | $35.8M | 1,131,257 | -13.4 | $5.3B | Healthcare |
| 27 | Royalty Pharma PLC Class A | RPRX | 1.12% | $35.1M | 602,164 | 23.7 | $25.3B | Healthcare |
| 28 | Kiniksa Pharmaceuticals International Plc Class A | KNSA | 1.10% | $34.2M | 451,557 | 70.8 | $5.8B | Healthcare |
| 29 | Vaxcyte Inc | PCVX | 1.09% | $34.1M | 600,995 | -7.4 | $8.2B | Healthcare |
| 30 | Spyre Therapeutics Inc | SYRE | 1.07% | $33.4M | 394,620 | -47.8 | $8.1B | Healthcare |
| 31 | Jazz Pharmaceuticals PLC | JAZZ | 1.04% | $32.4M | 139,299 | 15.5 | $14.8B | Healthcare |
| 32 | Moderna Inc | MRNA | 1.03% | $32.1M | 157,622 | -23.8 | $75.4B | Healthcare |
| 33 | Xenon Pharmaceuticals Inc | XENE | 0.94% | $29.3M | 787,371 | -8.0 | $3.7B | Healthcare |
| 34 | Bruker Corp | BRKR | 0.92% | $28.7M | 444,698 | -90.5 | $9.6B | Healthcare |
| 35 | Illumina Inc | ILMN | 0.91% | $28.3M | 104,058 | 50.5 | $41.3B | Healthcare |
| 36 | Veracyte Inc | VCYT | 0.89% | $27.8M | 603,125 | 31.8 | $3.7B | Healthcare |
| 37 | LifeStance Health Group Inc | LFST | 0.84% | $26.2M | 2,203,532 | 90.9 | $4.6B | Healthcare |
| 38 | Praxis Precision Medicines Inc | PRAX | 0.82% | $25.5M | 90,706 | -22.8 | $8.2B | Healthcare |
| 39 | Sartorius Stedim Biotech | DIM.PA | 0.77% | $24.0M | 97,542 | 68.9 | $20.3B | Healthcare |
| 40 | Kymera Therapeutics Inc | KYMR | 0.76% | $23.6M | 213,331 | -33.0 | $8.8B | Healthcare |
| 41 | Roivant Sciences Ltd | ROIV | 0.70% | $21.7M | 594,586 | -94.0 | $25.8B | Healthcare |
| 42 | MBX Biosciences Inc | MBX | 0.69% | $21.6M | 374,460 | -24.4 | $2.8B | Healthcare |
| 43 | Privia Health Group Inc | PRVA | 0.68% | $21.2M | 1,081,799 | 90.3 | $2.6B | Healthcare |
| 44 | Insmed Inc | INSM | 0.66% | $20.5M | 177,366 | -27.0 | $24.1B | Healthcare |
| 45 | Biogen Inc | BIIB | 0.65% | $20.3M | 89,378 | 38.7 | $32.5B | Healthcare |
| 46 | Relay Therapeutics Inc | RLAY | 0.63% | $19.6M | 1,066,623 | -12.1 | $4.2B | Healthcare |
| 47 | Legend Biotech Corp ADR | LEGN | 0.61% | $18.9M | 1,004,929 | -37.1 | $3.4B | Healthcare |
| 48 | Cencora Inc | COR | 0.60% | $18.7M | 60,730 | 22.9 | $60.1B | Healthcare |
| 49 | Dianthus Therapeutics Inc | DNTH | 0.56% | $17.5M | 200,269 | -678.5 | $4.9B | Healthcare |
| 50 | Axsome Therapeutics Inc | AXSM | 0.56% | $17.4M | 93,689 | -47.8 | $9.2B | Healthcare |